LongueVue Capital (“LVC”) is pleased to announce that its portfolio company Pinnacle Clinical Research (“Pinnacle” or the “Company”), a leading site organization founded by Dr. Stephen Harrison and specializing in complex therapeutic areas, has completed successful investments in Kerwin Medical Center (“KMC”), The Cognitive and Research Center of New Jersey (“CRCNJ”), Bellaire Clinical Research (“Bellaire”), Palmetto Clinical Research – Low Country (“Palmetto”), and Dallas Research Institute (“DRI”). These five additions to the Pinnacle network broaden Pinnacle’s geographic footprint to include twelve total sites across the U.S. In addition, the KMC and CRCNJ acquisitions expand Pinnacle’s therapeutic area expertise into central nervous system (“CNS”) indications with a focus on Alzheimer’s Disease (“AD”).
Read the full article: Pinnacle Clinical Research Accelerates Its Rapid Expansion with Multiple Acquisitions and Strategic Partnerships //
Source: https://www.prnewswire.com/news-releases/pinnacle-clinical-research-accelerates-its-rapid-expansion-with-multiple-acquisitions-and-strategic-partnerships-302175647.html